Prognostic impact of hypoxia-inducible factors 1α and 2α in colorectal cancer patients: Correlation with tumor angiogenesis and cyclooxygenase-2 expression

Clinical Cancer Research

Volumn 10, Issue 24, 2004, Pages 8554-8560

  Yoshimura, Hiroshi ^a   Dhar, Dipok Kumar ^a   Kohno, Hitoshi ^a   Kubota, Hirofumi ^a   Fujii, Toshiyuki ^a   Ueda, Shuhei ^a   Kinugasa, Shoichi ^a   Tachibana, Mitsuo ^a   Nagasue, Naofumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; LYMPH NODES; MALE; MEMBRANE PROTEINS; MICROCIRCULATION; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 11144222884     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0946-03     Document Type: Article

References (20)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
2. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-4.
3. Tanigawa Y, Amaya H, Matsumura M, Lu C, Kitaoka A, Matsuyama K. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 1997;57:1043-6.
4. Chio HJ, Hyun MS, Jung GJ, Kim SS, Hong SH. Tumor angiogenesis as a predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 1998;55:575-81.
5. Masunaga R, Kohno H, Dhar DK, et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 2000;6:4064-8.
6. Semenza GL. Expression of hypoxia-inducible factor 1: mechanism and consequences. Biochem Pharmacol 2000;59:47-53.
7. Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI. Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer (Phila) 2002;95:1055-63.
8. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60:4693-6.
9. Birner P, Gatterbauer B, Oberhuber G, et al. Expression of hypoxiainducible factor-1α in oligodendrogliomas. Cancer (Phila) 2001;92:165-71.
10. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumors and survival. Br J Cancer 2001;85:881-90.
11. Zhong H, Marzo AMD, Laughner E, et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999;59:5830-5.
12. Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000;157:411-21.
13. Tabara H, Kohno H, Dhar DK, et al. Concurrent expression of angiogenic growth factors and neovascularization during tumourigenesis in colorectal carcinoma patients. Acta Oncol 2001;40:622-8.
14. Fang J, Yan L, Shing Y, Moses A. HIF-1α mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res 2001;61:5731-5.
15. Matsumura M, Chiba Y, Lu C, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancer. Cancer Lett 1998;128:55-63.
16. Leek RD, Talks KL, Pezzella F, et al. Relation of hypoxia-inducible factor-2α (HIF2α) expression in tumor-infiltrative macrophages to tumor angiogenesis and oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res 2002;62:1326-9.
17. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40.
18. Jones MK, Szabo IL, Kawanaka H, Husain SS, Tarnawski AS. von Hippel Lindau tumor suppressor and HIF-1α: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J 2002;16:264-6.
19. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and response to chemotherapy. Clin Cancer Res 2001;7:1661-8.
20. Koukourakis MI, Giatromanolaki A, Skarlatos J, et al. Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 2001;61:1830-2.